# To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis

> **NCT02528760** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 83 (actual)

## Conditions studied

- Cirrhosis

## Interventions

- **DRUG:** Metaclopramide
- **DRUG:** Erythromycin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02528760
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09-24
- **Primary completion:** 2017-08-31
- **Final completion:** 2017-08-31
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2017-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02528760

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02528760, "To Determine the Role of Prokinetics in Feed Intolerance in Critically Ill Cirrhosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02528760. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*